Wednesday, October 01, 2014 9:29:19 AM
American Bulls gives it a 4* rating for the next 6 months.
LIQUIDMETAL TECHNOLOGIES
Last Signal: BUY
Last Pattern: BULLISH ENGULFING
Last Close:
0.1950
Change:
+0.0044
Percent change
+2.31%
+ to Portfolio
+ to Watchlist
6 mo. Rating 4?
$100? 158.55
12 mo. Rating 4?
$100? 254.09
24 mo. Rating 3?
$100? 635.91
Signal Update
Our system’s recommendation today is to BUY. The BULLISH ENGULFING pattern finally received a confirmation because the prices crossed above the confirmation level which was at 0.1906, and our valid average buying price stands now at 0.1922. The previous SELL recommendation was issued on 9/26/2014, 4 days ago, when the stock price was 0.1897. Since then LQMT has risen by +1.32%.
Market Outlook
We may be at a market bottom or at the start of a reaction rally. Let’s jump on our white horses and go for a bullish ride. Today’s candlestick has a white body and its close is above the confirmation level. The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated. Most probably, it is the right time to participate in bullish fervor. The market is telling you about a new profit. Do not miss this bullish opportunity.
Candlestick Pattern Chart
The chart showing Series 1 series.
Pattern Description
This pattern is characterized by a large white body engulfing a preceding smaller black body, which appears during a downtrend. The white body does not necessarily engulf the shadows of the black body but totally engulfs the body itself. This is an important bottom reversal signal. more...
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM